Voluntary Action Indicated (VAI) is an FDA inspection classification indicating that objectionable conditions were found, but formal enforcement action is not expected if corrections are made.
A VAI outcome signals that deficiencies require timely corrective and preventive actions to prevent escalation. Organizations typically respond by documenting root cause analysis, CAPA plans, and evidence of implementation. VAI findings can still affect sponsor confidence, quality oversight intensity, and inspection readiness planning. Prompt, well-documented remediation supports stronger compliance posture and reduces risk of repeat observations.